CTMX vs DG · rev $138.1M vs P/E 15, rev $40.61B
CytomX Therapeutics Inc (CTMX) versus Dollar General Corporation (DG) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Dollar General Corporation (DG) is a discount stores company listed on US.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
Latest reported DG revenue for 2025-01-31 was $40.61B. Net income was $1.13B. Revenue was up 5.0% from 2024-02-02 to 2025-01-31. DG currently screens at market cap $22.87B and trailing P/E 14.7.
CTMX currently screens at market cap $653.1M. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Not investment advice. Open the CTMX and DG stock pages for the full models.
Not investment advice.